Rare diseases
Investigational molecules
Locations
78 Blanchard Road Suite 200, 01803-6014, United States
Cardurion Pharmaceuticals Inc. focuses on heart failure, with research spanning heart failure with reduced ejection fraction and heart failure with preserved ejection fraction. Its clinical work is centered on cardiac biomarker-driven evaluation and treatment of chronic symptomatic disease.
The sponsor’s research interest in this area reflects a concentration on improving outcomes in patients with impaired cardiac performance and persistent circulatory stress.
Cardurion Pharmaceuticals Inc. runs clinical trials in conditions such as Ventricular tachycardia, Heart failure with reduced ejection fraction, Heart failure with preserved ejection fraction, among others.
Clinical trials run by this sponsor – those enrolling participants first.
France
BulgariaFrance
BelgiumBelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
